The expression of key genes for MAPK/ERK signaling, EGFR, ERK1, ERK2, c-Jun, and c-Fos, was analyzed according to different variables to investigate associations between patients’ specific features and the predisposition to develop pancreatic cancer. This evidence concerns the gene MAPK1 and familial pancreatic carcinoma.